Eli Lilly’s weight-loss drug succeeds in trials with sleep apnea patients
Eli Lilly’s weight-loss drug succeeded in two late-stage trials testing it in patients with obstructive sleep apnea, the company said on Wednesday.
Eli Lilly’s weight-loss drug succeeded in two late-stage trials testing it in patients with obstructive sleep apnea, the company said on Wednesday.
Osteopathic manipulative treatment should be considered for patients with Graves’ eye disease, especially those who cannot tolerate or afford medication or surgery.
Nature Communications – When the Marinoan snowball Earth deglaciated, the ocean’s chemistry determined the strength and duration of the ensuing supergreenhouse climate, while the sudden…
A World Health Organization official said on Tuesday there was a risk of H5N1 bird flu virus spreading to cows in other countries beyond the…
Objective Speech sound disorder (SSD) describes a ‘persistent difficulty with speech sound production that interferes with speech intelligibility or prevents verbal communication’. There is a…
Excluding pregnant people from research fails to prevent harm to them and their offspring — and actually increases it.
Nature – The tissue developed into functioning kidneys and produced urine.
What does it mean to eat foods that are “in season?” This article explores seasonal eating in-depth, from what it is to its benefits for…
National Institutes of Health researchers and collaborators have discovered over 100 new regions of the human genome, also known as genomic loci, that appear to…
About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk’s weight-loss…
Obesity, a public health challenge, arises from a complex interplay of factors such as dietary habits and genetic predisposition. Alterations in gut microbiota, characterized by…